CN1186063C - Medicine for treating diabetes and its complication - Google Patents
Medicine for treating diabetes and its complication Download PDFInfo
- Publication number
- CN1186063C CN1186063C CNB021338523A CN02133852A CN1186063C CN 1186063 C CN1186063 C CN 1186063C CN B021338523 A CNB021338523 A CN B021338523A CN 02133852 A CN02133852 A CN 02133852A CN 1186063 C CN1186063 C CN 1186063C
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- portions
- fructus
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating diabetes and the complications of diabetes. The present invention is prepared from the components of the portion by weight: 2 to 5 portions of ginseng, 2 to 5 portions of tokay gecko, 4 to 10 portions of rehmannia root, 4 to 10 portions of rhizoma dioscoreae from Hena of China, 4 to 10 portions of cornus, 4 to 10 portions of mulberry fruit, 4 to 10 portions of trichosanthes root, 4 to 10 portions of solomonseal rhizome, 4 to 10 portions of astragalus root, 4 to 10 portions of plaster stone, 3 to 6 portions of matrimony vine, 3 to 6 portions of radix asparagi, 6 to 8 portions of kudzuvine root, 4 to 8 portions of white atractylodes rhizome, 3 to 6 portions of schisandra fruit, 3 to 6 portions of cortex moutan root-bark of tree peony, 5 to 8 portions of prepared rhizome of rehmannia, 3 to 8 portions of oriental waterplantain rhizome, 3 to 8 portions of poria from Yunnan of China and 3 to 6 portions of common four-o'clock root. The present invention has specific curative effect on diabetes, has the curative effects of nourishing, restoring and activating the pancreatic island, enhancing the immune functions in vivo, harmonizing the five viscera, adjusting the sugar metabolism disturbance and the fat metabolism disturbance of an organism, promoting blood circulation, reducing the blood hypercoagulabale state and improving various vascular nerve complications, and realizes the purpose of radically treating diabetes and the complications of diabetes, such as coronary heart diseases, kidney disease, ketosis, peripheral neuropathy, etc.
Description
(1) technical field:
The present invention relates to a kind of Chinese patent medicine, particularly a kind of medicine for the treatment of diabetes and complication thereof.
(2) background technology:
Diabetes pathology causes change and often relates to each system of whole body, for this disease causes death, major cause of morbidity, still do not have ideal radical cure method at present, modern doctor trained in Western medicine seems at a loss what to do to it, though each show his special prowess for traditional traditional Chinese medical science, but because prescription is old assorted, the shakiness of excuting a law seldom has ideal curative effect and adaptability widely, in addition, the medicine of such treatment diabetes all can only be treated diabetes merely, can not doublely control concurrent disease.As application number is 00123416.1, name is called " a kind of production method for the treatment of the diabetes medicine " and application number is 94102060.6, name is called the Chinese patent of " a kind of instant hypoglycemic and hungry stopping chicken ginseng nutrient granules and preparation technology thereof ", all is the Chinese medicine that is purpose with simple treatment diabetes.
(3) summary of the invention:
The present invention will disclose a kind of good effect, can extensively adapt to all kinds diabetes and can treat the Chinese medicine of diabetic complication simultaneously.
A kind of medicine for the treatment of diabetes and complication thereof is made by following raw materials in weight portion: the Radix Astragali 4～10, Rhizoma Polygonati 4～10, Fructus Schisandrae Chinensis 3～6, Fructus Corni 3～5, Radix Mirabilis 3～6.
The optimization formula of above-mentioned prescription is: raw material also comprises Radix Ginseng, Gecko, and the weight portion proportioning of each raw material is: the Radix Astragali 4～8, Rhizoma Polygonati 4～10, Fructus Schisandrae Chinensis 3～6, Fructus Corni 6～10, Radix Mirabilis 3～5, Radix Ginseng 4～5, Gecko 4～5.
The optimization side of above-mentioned prescription is: raw material also comprises the Radix Rehmanniae, Rhizoma dioscoreae, Fructus Mori, pollen, Gypsum Fibrosum, Fructus Lycii, Radix Asparagi, Radix Puerariae, the Rhizoma Atractylodis Macrocephalae, Cortex Moutan, Radix Rehmanniae Preparata, Rhizoma Alismatis, Poria, and the weight portion proportioning of each raw material is: Radix Ginseng 2～5, Gecko 2～5, the Radix Rehmanniae 4～10, Rhizoma dioscoreae 4～10, Fructus Corni 4～10, Fructus Mori 4～10, pollen 4～10, Rhizoma Polygonati 4～10, the Radix Astragali 4～10, Gypsum Fibrosum 4～10, Fructus Lycii 3～6, Radix Asparagi 3～6, Radix Puerariae 6～8, the Rhizoma Atractylodis Macrocephalae 4～8, Fructus Schisandrae Chinensis 3～6, Cortex Moutan 3～6, Radix Rehmanniae Preparata 5～8, Rhizoma Alismatis 3～8, Poria 3～8, Radix Mirabilis 3～6.
The optimization formula that is used for the treatment of diabetes and complication ketosis thereof of above-mentioned prescription is: the weight portion proportioning of each raw material is a Radix Ginseng 2.5～3.5, Gecko 1.5～2.5, the Radix Rehmanniae 9～10, Rhizoma dioscoreae 9～10, Fructus Mori 9～10, pollen 9～10, Rhizoma Polygonati 9～10, the Radix Astragali 9～10, Gypsum Fibrosum 9～10, the Rhizoma Atractylodis Macrocephalae 2.5～3.5, Fructus Lycii 2.5～3.5, Radix Asparagi 2.5～3.5, Radix Puerariae 2.5～3.5, Fructus Corni 2.5～3.5, Fructus Schisandrae Chinensis 4～6, Radix Mirabilis 4～6.
The optimum formula that is used for the treatment of diabetes and complication ketosis thereof of above-mentioned prescription is: the weight portion proportioning of each raw material is a Radix Ginseng 3, Gecko 2, the Radix Rehmanniae 10, Rhizoma dioscoreae 10, Fructus Mori 10, pollen 10, Rhizoma Polygonati 10, the Radix Astragali 10, Gypsum Fibrosum 10, the Rhizoma Atractylodis Macrocephalae 3, Fructus Lycii 3, Radix Asparagi 3, Radix Puerariae 3, Fructus Corni 3, Fructus Schisandrae Chinensis 5, Radix Mirabilis 5.
The optimization formula that is used for the treatment of diabetes and complication nephropathy thereof of above-mentioned prescription is: described each parts by weight of raw materials proportioning is:
Radix Ginseng 1.5～2.5, Gecko 2.5～3.5, the Radix Rehmanniae 9～10, Rhizoma dioscoreae 9～10, Fructus Mori 9～10, pollen 9～10, Rhizoma Polygonati 9～10, the Radix Astragali 9～10, Gypsum Fibrosum 9～10, the Rhizoma Atractylodis Macrocephalae 1.5～2.5, Fructus Lycii 2.5～3.5, Radix Asparagi 2.5～3.5, Radix Puerariae 2.5～3.5, Fructus Corni 2.5～3.5, Fructus Schisandrae Chinensis 4.5～5.5, Radix Mirabilis 4.5～5.5.
The optimum formula that is used for the treatment of diabetes and complication nephropathy thereof of above-mentioned prescription is: the weight portion proportioning of described each raw material is:
Radix Ginseng 2, Gecko 3, the Radix Rehmanniae 10, Rhizoma dioscoreae 10, Fructus Mori 10, pollen 10, Rhizoma Polygonati 10, the Radix Astragali 10, Gypsum Fibrosum 10, the Rhizoma Atractylodis Macrocephalae 2, Fructus Lycii 3, Radix Asparagi 3, Radix Puerariae 3, Fructus Corni 3, Fructus Schisandrae Chinensis 5, Radix Mirabilis 5.
Above-mentioned prescription be used for the treatment of diabetes and the hypertensive optimization formula of complication is: the weight portion proportioning of described each raw material is:
Radix Ginseng 4～5, Gecko 4～5, the Radix Rehmanniae 9～10, Rhizoma dioscoreae 9～10, Fructus Mori 9～10, pollen 9～10, Rhizoma Polygonati 9～10, the Radix Astragali 9～10, Gypsum Fibrosum 9～10, the Rhizoma Atractylodis Macrocephalae 2.5～3.5, Fructus Lycii 2.5～3.5, Radix Asparagi 2.5～3.5, Radix Puerariae 2.5～3.5, Fructus Corni 2.5～3.5, Fructus Schisandrae Chinensis 2.5～3.5, Radix Mirabilis 1.5～2.5.
Above-mentioned prescription be used for the treatment of diabetes and the hypertensive optimum formula of complication is: the weight portion proportioning of described each raw material is:
Radix Ginseng 5, Gecko 5, the Radix Rehmanniae 10, Rhizoma dioscoreae 10, Fructus Mori 10, pollen 10, Rhizoma Polygonati 10, the Radix Astragali 10, Gypsum Fibrosum 10, the Rhizoma Atractylodis Macrocephalae 3, Fructus Lycii 3, Radix Asparagi 3, Radix Puerariae 3, Fructus Corni 3, Fructus Schisandrae Chinensis 3, Radix Mirabilis 2.
The present invention has following useful effectiveness:
(1) the treatment diabetes are effective, because this medicine not only combines the composition of refining of traditional treatment diabetes medicament, also increased the composition Radix Mirabilis simultaneously, also increased the principal agent Gecko, the content of Fructus Schisandrae Chinensis, make this medicine have special efficacy aspect the treatment diabetes, the energy nourishing pancreas islet, repair islets of langerhans, activate islets of langerhans, the intravital immunologic function of raising machine, push away to remove making new advances, peace is closed the five internal organs, adjusts body sugar thereby reach, fat metabolic disturbance, blood circulation promoting, reduce high blood coagulation state, improve the curative effect of various nervus vasculairs complication, reach the purpose of radical cure diabetes.Clinical 360 cases were checked once after the drug withdrawal in every month, and continuously half a year, cure rate reaches (glucose in urine, blood glucose reach normal index) more than 89%, and effective percentage reaches 93% (glucose in urine, blood glucose bounce-back descend 20～30% but the ratio treatment is preceding after the drug withdrawal).
(2) complication that can treat diabetes simultaneously is as coronary heart disease, nephropathy, ketosis, peripheral neuropathy etc.
(3) have no side effect.
(4) raw material is extensive, and is with low cost, convenient for production.
(4) specific embodiment:
Each composition of embodiment 1:(is all with the weight portion proportioning)
Get 10 parts of the Radixs Astragali, 10 parts of Rhizoma Polygonatis, 6 parts of Fructus Schisandrae Chinensis, 3 parts of Fructus Cornis, 3 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.
Each composition of embodiment 2:(is all with the weight portion proportioning)
Get 4 parts of the Radixs Astragali, 4 parts of Rhizoma Polygonatis, 3 parts of Fructus Schisandrae Chinensis, 5 parts of Fructus Cornis, 6 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.
Each composition of embodiment 3:(is all with the weight portion proportioning)
Get 4 parts of the Radixs Astragali, 4 parts of Rhizoma Polygonatis, 3 parts of Fructus Schisandrae Chinensis, 10 parts of Fructus Cornis, 3 parts of Radix Mirabiliss, 5 parts of Radix Ginsengs, 5 parts of any dosage forms of making on the pharmaceutics of Gecko.
Each composition of embodiment 4:(is all with the weight portion proportioning)
Get 8 parts of the Radixs Astragali, 10 parts of Rhizoma Polygonatis, 6 parts of Fructus Schisandrae Chinensis, 6 parts of Fructus Cornis, 5 parts of Radix Mirabiliss, 4 parts of Radix Ginsengs, 4 parts of any dosage forms of making on the pharmaceutics of Gecko.
Each composition of embodiment 5:(is all with the weight portion proportioning)
Get 8 parts of the Radixs Astragali, 10 parts of Rhizoma Polygonatis, 6 parts of Fructus Schisandrae Chinensis, 6 parts of Fructus Cornis, 5 parts of Radix Mirabiliss, 4 parts of Radix Ginsengs, 4 parts of Geckos, 10 parts in the Radix Rehmanniae, 8 parts of Rhizoma dioscoreaes, 10 parts in Fructus Mori, 7 parts of pollen, 10 parts of Gypsum Fibrosum, 6 parts of Fructus Lyciis, 5 parts of Radix Asparagis, 8 parts of Radix Puerariaes, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Cortex Moutans, 8 parts in Radix Rehmanniae Preparata, 8 parts of Rhizoma Alismatis, 8 parts of any dosage forms of making on the pharmaceutics of Poria.
Each composition of embodiment 6:(is all with the weight portion proportioning)
2 parts of Radix Ginsengs, 2 parts of Geckos, 4 parts in the Radix Rehmanniae, 4 parts of Rhizoma dioscoreaes, 4 parts of Fructus Cornis, 4 parts in Fructus Mori, 4 parts of pollen, 4 parts of Rhizoma Polygonatis, 4 parts of the Radixs Astragali, 10 parts of Gypsum Fibrosum, 6 parts of Fructus Lyciis, 6 parts of Radix Asparagis, 8 parts of Radix Puerariaes, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Fructus Schisandrae Chinensis, 6 parts of Cortex Moutans, 8 parts in Radix Rehmanniae Preparata, 8 parts of Rhizoma Alismatis, 8 parts of Poria, 6 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.
Each composition of embodiment 7:(is all with the weight portion proportioning)
5 parts of Radix Ginsengs, 5 parts of Geckos, 10 parts in the Radix Rehmanniae, 10 parts of Rhizoma dioscoreaes, 10 parts of Fructus Cornis, 10 parts in Fructus Mori, 10 parts of pollen, 10 parts of Rhizoma Polygonatis, 10 parts of the Radixs Astragali, 4 parts of Gypsum Fibrosum, 3 parts of Fructus Lyciis, 3 parts of Radix Asparagis, 6 parts of Radix Puerariaes, 4 parts of the Rhizoma Atractylodis Macrocephalaes, 3 parts of Fructus Schisandrae Chinensis, 3 parts of Cortex Moutans, 5 parts in Radix Rehmanniae Preparata, 3 parts of Rhizoma Alismatis, 3 parts of Poria, 3 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.
Each composition of embodiment 8:(is all with the weight portion proportioning)
2.5 parts of Radix Ginsengs, 1.5 parts of Geckos, 9 parts in the Radix Rehmanniae, Rhizoma dioscoreae 9,9 parts in Fructus Mori, 9 parts of pollen, 9 parts of Rhizoma Polygonatis, 9 parts of the Radixs Astragali, 10 parts of Gypsum Fibrosum, 3.5 parts of the Rhizoma Atractylodis Macrocephalaes, 3.5 parts of Fructus Lyciis, 3.5 parts of Radix Asparagis, 3.5 parts of Radix Puerariaes, 3.5 parts of Fructus Cornis, Fructus Schisandrae Chinensis 6, Radix Mirabilis 6 are made any dosage form on the pharmaceutics.
Each composition of embodiment 9:(is all with the weight portion proportioning)
3.5 parts of Radix Ginsengs, 2.5 parts of Geckos, 10 parts in the Radix Rehmanniae, 10 parts of Rhizoma dioscoreaes, 10 parts in Fructus Mori, 10 parts of pollen, 10 parts of Rhizoma Polygonatis, 10 parts of the Radixs Astragali, 9 parts of Gypsum Fibrosum, 2.5 parts of the Rhizoma Atractylodis Macrocephalaes, 2.5 parts of Fructus Lyciis, 2.5 parts of Radix Asparagis, 2.5 parts of Radix Puerariaes, 2.5 parts of Fructus Cornis, Fructus Schisandrae Chinensis 4, Radix Mirabilis 4 are made any dosage form on the pharmaceutics.
Each composition of embodiment 10:(is all with the weight portion proportioning)
3 parts of Radix Ginsengs, 2 parts of Geckos, 10 parts in the Radix Rehmanniae, 10 parts of Rhizoma dioscoreaes, 10 parts in Fructus Mori, 10 parts of pollen, 10 parts of Rhizoma Polygonatis, 10 parts of the Radixs Astragali, 10 parts of Gypsum Fibrosum, 3 parts of the Rhizoma Atractylodis Macrocephalaes, Fructus Lycii 3,3 parts of Radix Asparagis, 3 parts of Radix Puerariaes, 3 parts of Fructus Cornis, 5 parts of Fructus Schisandrae Chinensis, 5 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.Its instructions of taking is for be equivalent to 6 gram materials of effective ingredients at every turn, and every day 3 times, 30 days is a course of treatment, obeys 3～4 courses of treatment.We are based on treatment diabetes and its complication ketosis, and its cure rate is more than 90%.
Each composition of embodiment 11:(is all with the weight portion proportioning)
1.5 parts of Radix Ginsengs, 2.5 parts of Geckos, 9 parts in the Radix Rehmanniae, 9 parts of Rhizoma dioscoreaes, 9 parts in Fructus Mori, 9 parts of pollen, 9 parts of Rhizoma Polygonatis, 9 parts of the Radixs Astragali, 10 parts of Gypsum Fibrosum, 2.5 parts of the Rhizoma Atractylodis Macrocephalaes, 3.5 parts of Fructus Lyciis, 3.5 parts of Radix Asparagis, 3.5 parts of Radix Puerariaes, 3.5 parts of Fructus Cornis, 45.5 parts of Fructus Schisandrae Chinensis, 5.5 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.
Each composition of embodiment 12:(is all with the weight portion proportioning)
2.5 parts of Radix Ginsengs, 3.5 parts of Geckos, 10 parts in the Radix Rehmanniae, 10 parts of Rhizoma dioscoreaes, 10 parts in Fructus Mori, 10 parts of pollen, 10 parts of Rhizoma Polygonatis, 10 parts of the Radixs Astragali, 9 parts of Gypsum Fibrosum, 1.5 parts of the Rhizoma Atractylodis Macrocephalaes, 2.5 parts of Fructus Lyciis, 2.5 parts of Radix Asparagis, 2.5 parts of Radix Puerariaes, 2.5 parts of Fructus Cornis, 4.5 parts of Fructus Schisandrae Chinensis, 4.5 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.
Each composition of embodiment 13:(is all with the weight portion proportioning)
2 parts of Radix Ginsengs, 3 parts of Geckos, 10 parts in the Radix Rehmanniae, 10 parts of Rhizoma dioscoreaes, 10 parts in Fructus Mori, 10 parts of pollen, 10 parts of Rhizoma Polygonatis, 10 parts of the Radixs Astragali, 10 parts of Gypsum Fibrosum, 2 parts of the Rhizoma Atractylodis Macrocephalaes, 3 parts of Fructus Lyciis, 3 parts of Radix Asparagis, 3 parts of Radix Puerariaes, 3 parts of Fructus Cornis, 5 parts of Fructus Schisandrae Chinensis, 5 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.Its instructions of taking is for be equivalent to 5 gram materials of effective ingredients at every turn, and every day 3 times, 30 days is a course of treatment, obeys 4～5 courses of treatment.We are based on treatment diabetes and its complication nephropathy, and its cure rate is more than 89%.
Each composition of embodiment 14:(is all with the weight portion proportioning)
4 parts of Radix Ginsengs, 4 parts of Geckos, 9 parts in the Radix Rehmanniae, 9 parts of Rhizoma dioscoreaes, 9 parts in Fructus Mori, 9 parts of pollen, 9 parts of Rhizoma Polygonatis, 9 parts of the Radixs Astragali, 10 parts of Gypsum Fibrosum, 3.5 parts of the Rhizoma Atractylodis Macrocephalaes, 3.5 parts of Fructus Lyciis, 3.5 parts of Radix Asparagis, 3.5 parts of Radix Puerariaes, 3.5 parts of Fructus Cornis, 3.5 parts of Fructus Schisandrae Chinensis, 2.5 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.
Each composition of embodiment 15:(is all with the weight portion proportioning)
5 parts of Radix Ginsengs, 5 parts of Geckos, 10 parts in the Radix Rehmanniae, 10 parts of Rhizoma dioscoreaes, 10 parts in Fructus Mori, 10 parts of pollen, 10 parts of Rhizoma Polygonatis, 10 parts of the Radixs Astragali, 10 parts of Gypsum Fibrosum, 3.5 parts of the Rhizoma Atractylodis Macrocephalaes, 3.5 parts of Fructus Lyciis, 3.5 parts of Radix Asparagis, 3.5 parts of Radix Puerariaes, 3.5 parts of Fructus Cornis, 3.5 parts of Fructus Schisandrae Chinensis, 2.5 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.
Each composition of embodiment 16:(is all with the weight portion proportioning)
5 parts of Radix Ginsengs, 5 parts of Geckos, 10 parts in the Radix Rehmanniae, 10 parts of Rhizoma dioscoreaes, 10 parts in Fructus Mori, 10 parts of pollen, 10 parts of Rhizoma Polygonatis, 10 parts of the Radixs Astragali, 10 parts of Gypsum Fibrosum, 3 parts of the Rhizoma Atractylodis Macrocephalaes, 3 parts of Fructus Lyciis, Radix Asparagi part, 3 parts of Radix Puerariaes, 3 parts of Fructus Cornis, 3 parts of Fructus Schisandrae Chinensis, 2 parts of any dosage forms of making on the pharmaceutics of Radix Mirabilis.Its instructions of taking is for be equivalent to 4 gram materials of effective ingredients at every turn, and every day 3 times, 30 days is a course of treatment, obeys 5～6 courses of treatment.We are based on treatment diabetes and its complication coronary heart disease, and its cure rate is more than 88%.
Claims (9)
1, a kind of medicine for the treatment of diabetes and complication thereof is characterized in that being made by following raw materials in weight portion: the Radix Astragali 4～10, Rhizoma Polygonati 4～10, Fructus Schisandrae Chinensis 3～6, Fructus Corni 3～5, Radix Mirabilis 3～6.
2, a kind of medicine for the treatment of diabetes and complication thereof according to claim 1, it is characterized in that: raw material also comprises Radix Ginseng, Gecko, the weight portion proportioning of each raw material is the Radix Astragali 4～8, Rhizoma Polygonati 4～10, Fructus Schisandrae Chinensis 3～6, Fructus Corni 6～10, Radix Mirabilis 3～5, Radix Ginseng 4～5, Gecko 4～5.
3, a kind of medicine for the treatment of diabetes and complication thereof according to claim 2, it is characterized in that: raw material also comprises the Radix Rehmanniae, Rhizoma dioscoreae, Fructus Mori, pollen, Gypsum Fibrosum, Fructus Lycii, Radix Asparagi, Radix Puerariae, the Rhizoma Atractylodis Macrocephalae, Cortex Moutan, Radix Rehmanniae Preparata, Rhizoma Alismatis, Poria, the weight portion proportioning of each raw material is a Radix Ginseng 2～5, Gecko 2～5, the Radix Rehmanniae 4～10, Rhizoma dioscoreae 4～10, Fructus Corni 4～10, Fructus Mori 4～10, pollen 4～10, Rhizoma Polygonati 4～10, the Radix Astragali 4～10, Gypsum Fibrosum 4～10, Fructus Lycii 3～6, Radix Asparagi 3～6, Radix Puerariae 6～8, the Rhizoma Atractylodis Macrocephalae 4～8, Fructus Schisandrae Chinensis 3～6, Cortex Moutan 3～6, Radix Rehmanniae Preparata 5～8, Rhizoma Alismatis 3～8, Poria 3～8, Radix Mirabilis 3～6.
4, a kind of medicine for the treatment of diabetes and complication thereof is characterized in that the weight portion proportioning of described each raw material is: Radix Ginseng 2.5～3.5, Gecko 1.5～2.5, the Radix Rehmanniae 9～10, Rhizoma dioscoreae 9～10, Fructus Mori 9～10, pollen 9～10, Rhizoma Polygonati 9～10, the Radix Astragali 9～10, Gypsum Fibrosum 9～10, the Rhizoma Atractylodis Macrocephalae 2.5～3.5, Fructus Lycii 2.5～3.5, Radix Asparagi 2.5～3.5, Radix Puerariae 2.5～3.5, Fructus Corni 2.5～3.5, Fructus Schisandrae Chinensis 4～6, Radix Mirabilis 4～6.
5, a kind of medicine for the treatment of diabetes and complication thereof according to claim 4 is characterized in that the weight portion proportioning of described each raw material is: Radix Ginseng 3, Gecko 2, the Radix Rehmanniae 10, Rhizoma dioscoreae 10, Fructus Mori 10, pollen 10, Rhizoma Polygonati 10, the Radix Astragali 10, Gypsum Fibrosum 10, the Rhizoma Atractylodis Macrocephalae 3, Fructus Lycii 3, Radix Asparagi 3, Radix Puerariae 3, Fructus Corni 3, Fructus Schisandrae Chinensis 5, Radix Mirabilis 5.
6, a kind of medicine for the treatment of diabetes and complication thereof is characterized in that the weight portion proportioning of described each raw material is: Radix Ginseng 1.5～2.5, Gecko 2.5～3.5, the Radix Rehmanniae 9～10, Rhizoma dioscoreae 9～10, Fructus Mori 9～10, pollen 9～10, Rhizoma Polygonati 9～10, the Radix Astragali 9～10, Gypsum Fibrosum 9～10, the Rhizoma Atractylodis Macrocephalae 1.5～2.5, Fructus Lycii 2.5～3.5, Radix Asparagi 2.5～3.5, Radix Puerariae 2.5～3.5, Fructus Corni 2.5～3.5, Fructus Schisandrae Chinensis 4.5～5.5, Radix Mirabilis 4.5～5.5.
7, a kind of medicine for the treatment of diabetes and complication thereof according to claim 6 is characterized in that the weight portion proportioning of described each raw material is: Radix Ginseng 2, Gecko 3, the Radix Rehmanniae 10, Rhizoma dioscoreae 10, Fructus Mori 10, pollen 10, Rhizoma Polygonati 10, the Radix Astragali 10, Gypsum Fibrosum 10, the Rhizoma Atractylodis Macrocephalae 2, Fructus Lycii 3, Radix Asparagi 3, Radix Puerariae 3, Fructus Corni 3, Fructus Schisandrae Chinensis 5, Radix Mirabilis 5.
8, a kind of medicine for the treatment of diabetes and complication thereof is characterized in that the weight portion proportioning of described each raw material is: Radix Ginseng 4～5, Gecko 4～5, the Radix Rehmanniae 9～10, Rhizoma dioscoreae 9～10, Fructus Mori 9～10, pollen 9～10, Rhizoma Polygonati 9～10, the Radix Astragali 9～10, Gypsum Fibrosum 9～10, the Rhizoma Atractylodis Macrocephalae 2.5～3.5, Fructus Lycii 2.5～3.5, Radix Asparagi 2.5～3.5, Radix Puerariae 2.5～3.5, Fructus Corni 2.5～3.5, Fructus Schisandrae Chinensis 2.5～3.5, Radix Mirabilis 1.5～2.5.
9, a kind of medicine for the treatment of diabetes and complication thereof according to claim 8 is characterized in that the weight portion proportioning of described each raw material is: Radix Ginseng 5, Gecko 5, the Radix Rehmanniae 10, Rhizoma dioscoreae 10, Fructus Mori 10, pollen 10, Rhizoma Polygonati 10, the Radix Astragali 10, Gypsum Fibrosum 10, the Rhizoma Atractylodis Macrocephalae 3, Fructus Lycii 3, Radix Asparagi 3, Radix Puerariae 3, Fructus Corni 3, Fructus Schisandrae Chinensis 3, Radix Mirabilis 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021338523A CN1186063C (en) | 2002-09-29 | 2002-09-29 | Medicine for treating diabetes and its complication |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021338523A CN1186063C (en) | 2002-09-29 | 2002-09-29 | Medicine for treating diabetes and its complication |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1403135A CN1403135A (en) | 2003-03-19 |
| CN1186063C true CN1186063C (en) | 2005-01-26 |
Family
ID=4747424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021338523A Expired - Fee Related CN1186063C (en) | 2002-09-29 | 2002-09-29 | Medicine for treating diabetes and its complication |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1186063C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393946A (en) * | 2013-08-06 | 2013-11-20 | 天津太平洋制药有限公司 | Drug for treating type-2 diabetes |
| CN107441281A (en) * | 2017-08-04 | 2017-12-08 | 绿都中草药研发中心（北京）有限公司 | A kind of diabetes integrate compound preparation |
-
2002
- 2002-09-29 CN CNB021338523A patent/CN1186063C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1403135A (en) | 2003-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1201776C (en) | Medicines composition for treating diabetes and its prepn | |
| CN1853702A (en) | Chinese medicinal preparation for lowering blood sugar, blood fat and blood pressure, improving blood flow and immune and its making method | |
| CN1186063C (en) | Medicine for treating diabetes and its complication | |
| CN104606487A (en) | Fermented traditional Chinese medicine preparation as well as preparation method and application thereof | |
| CN1149097C (en) | Chinese patent medicine for curing diabetes | |
| CN1895646A (en) | Chinese medicine for treating diabetes mellitus and its preparation | |
| CN1253190C (en) | Medicine for treating diabetes | |
| CN1066332C (en) | Hypoglycemic compound capsule | |
| CN1857599A (en) | Medicine for lowering blood sugar, blood fat and blood pressure, raising blood flow rate and raising immunity and its preparing method | |
| CN1792372A (en) | Traditional Chinese medicine prepn. for treating diabetes | |
| CN1857605A (en) | Medicine for treating chronic alcoholic hepatopathy and its preparing method | |
| CN1611232A (en) | Medicinal composition with main effect of antifatigue, radioresistance and melancholia-resistance and its preparing method | |
| CN1241634C (en) | Medicine for treating diabetes | |
| CN1127344C (en) | Oral pill for curing diabetes and its complication | |
| CN1202847C (en) | Diabetes treating medicine | |
| CN1211426A (en) | Medicine for treating diabetes | |
| CN1272054C (en) | Medicine for treating diabetes and its preparing process | |
| CN1973850A (en) | Medicine composition for treating allergic rhinitis and its prepn process | |
| CN1698863A (en) | Chinese medicinal preparation for treating hyperosteogeny | |
| CN1285367C (en) | Medicinal preparation for treating diabetes and its preparation method | |
| CN1221273C (en) | Medication composition for diabetes | |
| CN1101213C (en) | Diabetes treating medicine | |
| CN1864728A (en) | Prescription and preparation method of yin-nourishing capsule containing ginseng and astragalus root | |
| CN1394638A (en) | New medicine for curing diobetes | |
| CN1342483A (en) | Medicine for treating diabetes and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |